Aura Biosciences Appoints New Chief Financial Officer

Aura Biosciences Inc ( (AURA) ) has issued an update.

Aura Biosciences has appointed Anthony Gibney as the Chief Financial and Business Officer effective May 13, 2025, as part of strengthening its leadership team. Gibney, with over 30 years of experience in biotechnology and investment banking, will play a crucial role in guiding the company’s financial strategy and business operations. The company also reported its first-quarter 2025 financial results, highlighting ongoing developments in its ocular and urologic oncology programs, including the global Phase 3 CoMpass trial for early-stage choroidal melanoma and a Phase 1b/2 trial for non-muscle-invasive bladder cancer. Aura’s financial position remains strong, with cash reserves expected to fund operations into the second half of 2026.

The most recent analyst rating on (AURA) stock is a Buy with a $21.00 price target. To see the full list of analyst forecasts on Aura Biosciences Inc stock, see the AURA Stock Forecast page.

Spark’s Take on AURA Stock

According to Spark, TipRanks’ AI Analyst, AURA is a Neutral.

Aura Biosciences’ overall stock score reflects its early-stage biotech profile, characterized by no revenue, increasing losses, and negative cash flows. While the company maintains a solid balance sheet, its stock faces bearish technical indicators and speculative valuation. The recent board appointment is a positive development, but the company’s financial health and market trends remain the primary concerns.

To see Spark’s full report on AURA stock, click here.

More about Aura Biosciences Inc

Aura Biosciences is a clinical-stage biotechnology company based in Boston, MA, focused on developing precision therapies for solid tumors with the aim of preserving organ function. Their lead candidate, bel-sar (AU-011), is in late-stage development for primary choroidal melanoma and early-stage development for other ocular oncology indications and bladder cancer.

Average Trading Volume: 274,589

Technical Sentiment Signal: Sell

Current Market Cap: $264.4M

See more insights into AURA stock on TipRanks’ Stock Analysis page.